Bezek S, Scasnár V, Trnovec T, Grupe R
Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, CSFR.
Pharmazie. 1991 Nov;46(11):810-1.
Biliary excretion of bendamustin (Cytostasan, 5-[bis(2-chloroethyl)amino]-i-methylbenzimidazole-2-butyric acid; 1) and its metabolites was studied in rats after i.v. administration of 14C-1. The most significant finding was the rapid excretion of 1 related radioactivity in the bile occurring shortly after injection. While radioactivity eliminated by bile within 2 h was 41.8%, in the course of subsequent 22 h it amounted only to 3.2%. Bile samples analyzed by TLC indicated that the total amount of radioactivity was excreted in the form of conjugates and two hydroxy metabolites. A significant amount of radioactivity was excreted in urine. The diversion of bile by cannulation of the bile duct led to a significant decrease of elimination by feces.
在大鼠静脉注射14C标记的苯达莫司汀(Cytostasan,5-[双(2-氯乙基)氨基]-1-甲基苯并咪唑-2-丁酸;1)后,研究了其胆汁排泄及其代谢产物。最显著的发现是注射后不久,1相关放射性在胆汁中迅速排泄。虽然2小时内胆汁消除的放射性为41.8%,但在随后的22小时内仅为3.2%。通过薄层层析分析的胆汁样本表明,放射性总量以结合物和两种羟基代谢产物的形式排泄。大量放射性从尿液中排泄。通过胆管插管使胆汁改道导致粪便消除量显著减少。